{"id":18272,"date":"2014-07-22T04:30:00","date_gmt":"2014-07-22T02:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/allergan-ribadisce-no-a-valeant-e-taglia-1-500-posti-lavoro-2\/"},"modified":"2014-07-22T04:30:00","modified_gmt":"2014-07-22T02:30:00","slug":"allergan-ribadisce-no-a-valeant-e-taglia-1-500-posti-lavoro-2","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/allergan-ribadisce-no-a-valeant-e-taglia-1-500-posti-lavoro-2\/","title":{"rendered":"Allergan reiterates no to Valeant and cuts 1,500 jobs"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; vertical-align: baseline; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"><span style=\"font-size:9.0pt; font-family:&quot;Helvetica&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;; mso-bidi-font-family:&quot;Times New Roman&quot;;color:#CD2229;text-transform:uppercase; mso-fareast-language:IT\"><a href=\"http:\/\/america24.com\/u\/stefania\" target=\"_blank\" rel=\"noopener\"><span style=\"color:#CD2229;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm; padding:0cm;text-decoration:none;text-underline:none\"><br \/> STEFANIA ARCUDI<\/span><\/a><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt; vertical-align: baseline; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"><span style=\"font-size:9.0pt; font-family:&quot;Helvetica&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;; mso-bidi-font-family:&quot;Times New Roman&quot;;color:#666666;text-transform:uppercase; mso-fareast-language:IT\"><a href=\"http:\/\/america24.com\/news\/allergan-ribadisce-no-valeant-taglia-500-posti-lavoro\" target=\"_blank\" rel=\"noopener\">21 JULY 2014 \u2013 <span style=\"font-family:&quot;Times New Roman&quot;,&quot;serif&quot;\">america24<\/span><\/a><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 7.5pt; line-height: 18pt; vertical-align: baseline; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"><span style=\"font-size: large;\"><span style=\"font-family: Georgia, serif;\">Allergan, the pharmaceutical company that makes Botox, reported better-than-expected profits in the second quarter and reiterated its no to a $53 billion cash and stock takeover offer from Valeant Pharmaceuticals International. The company also said it will cut 1,500 jobs, 13% of the total, generating $475 million in pre-tax savings in 2015.<\/span><\/span><span style=\"font-size:12.0pt;font-family:&quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:&quot;Times New Roman&quot;; mso-fareast-language:IT\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 7.5pt; line-height: 18pt; vertical-align: baseline; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"><span style=\"font-size: large;\"><span style=\"font-family: Georgia, serif;\">To reduce staff, Allergan will incur one-time charges of $375 million to $425 million related to severance payments and other restructuring costs. In the three months, the company reported profits of $417.2 million, with revenue up 15.9% to $1.827 billion.<\/span><\/span><span style=\"font-size:12.0pt;font-family:&quot;Georgia&quot;,&quot;serif&quot;; mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:&quot;Times New Roman&quot;; mso-fareast-language:IT\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 7.5pt; line-height: 18pt; vertical-align: baseline; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;\"><span style=\"font-size: large;\"><span style=\"font-family: Georgia, serif;\">The profit for the second quarter, amounting to 1.37 d<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; STEFANIA ARCUDI 21 LUGLIO 2014 &ndash; america24 Allergan, la societ&agrave; farmaceutica che produce il Botox, ha riportato profitti migliori delle aspettative nel secondo trimestre e ha ribadito il proprio no all&#8217;offerta d&#8217;acquisto da 53 miliardi di dollari in contante e azioni presentata da Valeant Pharmaceuticals International. La societ&agrave; ha inoltre fatto sapere che taglier&agrave; &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-18272","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=18272"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18272\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=18272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=18272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=18272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}